Danpure C J, Purdue P E, Fryer P, Griffiths S, Allsop J, Lumb M J, Guttridge K M, Jennings P R, Scheinman J I, Mauer S M
Biochemical Genetics Research Group, Medical Research Council Clinical Research Centre, Harrow, Middlesex, United Kingdom.
Am J Hum Genet. 1993 Aug;53(2):417-32.
Primary hyperoxaluria type 1 (PH1) is a rare autosomal recessive disease caused by a deficiency of the liver-specific peroxisomal enzyme alanine:glyoxylate aminotransferase (AGT). Three unrelated PH1 patients, who possess a novel complex phenotype, are described. At the enzymological level, this phenotype is characterized by a complete, or nearly complete, absence of AGT catalytic activity and reduced AGT immunoreactivity. Unlike normal individuals in whom the AGT is confined to the peroxisomal matrix, the immunoreactive AGT in these three patients was distributed approximately equally between the peroxisomes and mitochondria. The peroxisomal AGT appeared to be aggregated into amorphous core-like structures in which no other peroxisomal enzymes could be identified. Mutational analysis of the AGT gene showed that two of the three patients were compound heterozygotes for two previously unrecognized point mutations which caused Gly41-->Arg and Phe152-->Iso amino acid substitutions. The third patient was shown to be a compound heterozygote for the Gly41-->Arg mutation and a previously recognized Gly170-->Arg mutation. All three patients were homozygous for the Pro11-->Leu polymorphism that had been found previously with a high allelic frequency in normal populations. It is suggested that the Phe152-->Iso and Gly170-->Arg substitutions, which are only eighteen residues apart and located in the same highly conserved internal region of 58 amino acids, might be involved in the inhibition of peroxisomal targeting and/or import of AGT and, in combination with the Pro11-->Leu polymorphism, be responsible for its aberrant mitochondrial compartmentalization. On the other hand, the Gly41-->Arg substitution, either in combination with the Pro11-->Leu polymorphism or by itself, is predicted to be responsible for the intraperoxisomal aggregation of the AGT protein.
1型原发性高草酸尿症(PH1)是一种罕见的常染色体隐性疾病,由肝脏特异性过氧化物酶体酶丙氨酸:乙醛酸转氨酶(AGT)缺乏引起。本文描述了3例具有新的复杂表型的非亲缘关系的PH1患者。在酶学水平上,这种表型的特征是AGT催化活性完全或几乎完全缺失,以及AGT免疫反应性降低。与AGT局限于过氧化物酶体基质的正常个体不同,这3例患者中的免疫反应性AGT在过氧化物酶体和线粒体之间的分布大致相等。过氧化物酶体AGT似乎聚集成无定形的核心样结构,在其中无法鉴定出其他过氧化物酶体酶。AGT基因的突变分析表明,3例患者中有2例是两个先前未识别的点突变的复合杂合子,这两个点突变导致了Gly41→Arg和Phe152→Iso氨基酸替换。第3例患者被证明是Gly41→Arg突变和先前识别的Gly170→Arg突变的复合杂合子。所有3例患者均为Pro11→Leu多态性的纯合子,该多态性先前在正常人群中具有较高的等位基因频率。有人提出,Phe152→Iso和Gly170→Arg替换仅相隔18个残基,且位于58个氨基酸的同一高度保守的内部区域,可能参与抑制AGT的过氧化物酶体靶向和/或导入,并与Pro11→Leu多态性一起,导致其异常的线粒体分布。另一方面,Gly41→Arg替换,无论是与Pro11→Leu多态性组合还是单独存在,预计都导致AGT蛋白在过氧化物酶体内聚集。